Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malignant Melanoma

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 54 articles:
HTML format



Single Articles


    April 2021
  1. FALAHAT R, Berglund A, Putney RM, Perez-Villarroel P, et al
    Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    March 2021
  2. TENGESDAL IW, Menon DR, Osborne DG, Neff CP, et al
    Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    December 2020
  3. PATUTINA OA, Gaponova Miroshnichenko SK, Sen'kova AV, Savin IA, et al
    Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency.
    Proc Natl Acad Sci U S A. 2020;117:32370-32379.
    PubMed     Abstract available


  4. EISINGER S, Sarhan D, Boura VF, Ibarlucea-Benitez I, et al
    Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells.
    Proc Natl Acad Sci U S A. 2020;117:32005-32016.
    PubMed     Abstract available


    November 2020
  5. LU Y, Sandoval A, Voss S, Lai Z, et al
    Oncogenic allelic interaction in Xiphophorus highlights hybrid incompatibility.
    Proc Natl Acad Sci U S A. 2020;117:29786-29794.
    PubMed     Abstract available


    August 2020
  6. DEAN DN, Lee JC
    Defining an amyloid link Between Parkinson's disease and melanoma.
    Proc Natl Acad Sci U S A. 2020 Aug 31. pii: 2009702117.
    PubMed     Abstract available


  7. LI N, Kang Y, Wang L, Huff S, et al
    ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment.
    Proc Natl Acad Sci U S A. 2020;117:20159-20170.
    PubMed     Abstract available


    July 2020
  8. TAN J, Liu R, Zhu G, Umbricht CB, et al
    TERT promoter mutation determines apoptotic and therapeutic responses of BRAF-mutant cancers to BRAF and MEK inhibitors: Achilles Heel.
    Proc Natl Acad Sci U S A. 2020;117:15846-15851.
    PubMed     Abstract available


    June 2020
  9. LEX K, Maia Gil M, Lopes-Bastos B, Figueira M, et al
    Telomere shortening produces an inflammatory environment that increases tumor incidence in zebrafish.
    Proc Natl Acad Sci U S A. 2020;117:15066-15074.
    PubMed     Abstract available


    May 2020
  10. PYO A, Kim DY, Kim H, Lim D, et al
    Ultrasensitive detection of malignant melanoma using PET molecular imaging probes.
    Proc Natl Acad Sci U S A. 2020 May 21. pii: 1922313117.
    PubMed     Abstract available


    April 2020

  11. Correction for AbuHammad et al., Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.
    Proc Natl Acad Sci U S A. 2020 Apr 20. pii: 2005945117.
    PubMed    


    March 2020
  12. NICOLET BP, Guislain A, van Alphen FPJ, Gomez-Eerland R, et al
    CD29 identifies IFN-gamma-producing human CD8(+) T cells with an increased cytotoxic potential.
    Proc Natl Acad Sci U S A. 2020;117:6686-6696.
    PubMed     Abstract available


  13. SHARMA S, Zhang T, Michowski W, Rebecca VW, et al
    Targeting the cyclin-dependent kinase 5 in metastatic melanoma.
    Proc Natl Acad Sci U S A. 2020 Mar 19. pii: 1912617117.
    PubMed     Abstract available


  14. HERMANS D, Gautam S, Garcia-Canaveras JC, Gromer D, et al
    Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8(+) T cell stemness and antitumor immunity.
    Proc Natl Acad Sci U S A. 2020;117:6047-6055.
    PubMed     Abstract available


    February 2020
  15. TZENG SY, Patel KK, Wilson DR, Meyer RA, et al
    In situ genetic engineering of tumors for long-lasting and systemic immunotherapy.
    Proc Natl Acad Sci U S A. 2020;117:4043-4052.
    PubMed     Abstract available


  16. MULLOKANDOV G, Vijayakumar G, Leon P, Henry C, et al
    High-complexity extracellular barcoding using a viral hemagglutinin.
    Proc Natl Acad Sci U S A. 2020;117:2767-2769.
    PubMed     Abstract available


    December 2019
  17. LEE CJ, An HJ, Kim SM, Yoo SM, et al
    FBXW7-mediated stability regulation of signal transducer and activator of transcription 2 in melanoma formation.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1909879116.
    PubMed     Abstract available


    November 2019
  18. PREMI S, Han L, Mehta S, Knight J, et al
    Genomic sites hypersensitive to ultraviolet radiation.
    Proc Natl Acad Sci U S A. 2019 Nov 13. pii: 1907860116.
    PubMed     Abstract available


  19. LINETTE GP, Becker-Hapak M, Skidmore ZL, Baroja ML, et al
    Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.
    Proc Natl Acad Sci U S A. 2019 Nov 4. pii: 1906026116.
    PubMed     Abstract available


    August 2019
  20. WANG X, Sun R, Hao X, Lian ZX, et al
    IL-17 constrains natural killer cell activity by restraining IL-15-driven cell maturation via SOCS3.
    Proc Natl Acad Sci U S A. 2019;116:17409-17418.
    PubMed     Abstract available


  21. ABUHAMMAD S, Cullinane C, Martin C, Bacolas Z, et al
    Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.
    Proc Natl Acad Sci U S A. 2019 Aug 22. pii: 1901323116.
    PubMed     Abstract available


  22. ZHANG Y, Fang C, Wang RE, Wang Y, et al
    A tumor-targeted immune checkpoint blocker.
    Proc Natl Acad Sci U S A. 2019;116:15889-15894.
    PubMed     Abstract available


    February 2019
  23. LITSCHKO C, Bruhmann S, Csiszar A, Stephan T, et al
    Functional integrity of the contractile actin cortex is safeguarded by multiple Diaphanous-related formins.
    Proc Natl Acad Sci U S A. 2019;116:3594-3603.
    PubMed     Abstract available


  24. LI C, Nguyen V, Clark KN, Zahed T, et al
    Down-regulation of FZD3 receptor suppresses growth and metastasis of human melanoma independently of canonical WNT signaling.
    Proc Natl Acad Sci U S A. 2019 Feb 21. pii: 1813802116.
    PubMed     Abstract available


  25. GUPTA R, Bugide S, Wang B, Green MR, et al
    Loss of BOP1 confers resistance to BRAF kinase inhibitors in melanoma by activating MAP kinase pathway.
    Proc Natl Acad Sci U S A. 2019 Feb 19. pii: 1821889116.
    PubMed     Abstract available


  26. CHEUNG LS, Fu J, Kumar P, Kumar A, et al
    Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti-PD-1 in melanoma.
    Proc Natl Acad Sci U S A. 2019 Feb 4. pii: 1815087116.
    PubMed     Abstract available


    January 2019
  27. MIROSHNICHENKO SK, Patutina OA, Burakova EA, Chelobanov BP, et al
    Mesyl phosphoramidate antisense oligonucleotides as an alternative to phosphorothioates with improved biochemical and biological properties.
    Proc Natl Acad Sci U S A. 2019;116:1229-1234.
    PubMed     Abstract available


  28. BLANDO J, Sharma A, Higa MG, Zhao H, et al
    Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.
    Proc Natl Acad Sci U S A. 2019 Jan 11. pii: 1811067116.
    PubMed     Abstract available


  29. SANTANA CARRERO RM, Beceren-Braun F, Rivas SC, Hegde SM, et al
    IL-15 is a component of the inflammatory milieu in the tumor microenvironment promoting antitumor responses.
    Proc Natl Acad Sci U S A. 2019;116:599-608.
    PubMed     Abstract available


    December 2018
  30. DU X, de Almeida P, Manieri N, de Almeida Nagata D, et al
    CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1.
    Proc Natl Acad Sci U S A. 2018;115:E11731-E11740.
    PubMed     Abstract available


  31. SANG B, Zhang YY, Guo ST, Kong LF, et al
    Dual functions for OVAAL in initiation of RAF/MEK/ERK prosurvival signals and evasion of p27-mediated cellular senescence.
    Proc Natl Acad Sci U S A. 2018;115:E11661-E11670.
    PubMed     Abstract available


    September 2018
  32. NGEOW KC, Friedrichsen HJ, Li L, Zeng Z, et al
    BRAF/MAPK and GSK3 signaling converges to control MITF nuclear export.
    Proc Natl Acad Sci U S A. 2018;115:E8668-E8677.
    PubMed     Abstract available


    August 2018
  33. WANG Y, Su L, Morin MD, Jones BT, et al
    Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti-PD-L1 to eliminate melanoma in mice.
    Proc Natl Acad Sci U S A. 2018 Aug 27. pii: 1809232115.
    PubMed     Abstract available


  34. YANG Y, Jang GB, Yang X, Wang Q, et al
    Central role of autophagic UVRAG in melanogenesis and the suntan response.
    Proc Natl Acad Sci U S A. 2018;115:E7728-E7737.
    PubMed     Abstract available


  35. DATTA S, Misra SK, Saha ML, Lahiri N, et al
    Orthogonal self-assembly of an organoplatinum(II) metallacycle and cucurbit[8]uril that delivers curcumin to cancer cells.
    Proc Natl Acad Sci U S A. 2018;115:8087-8092.
    PubMed     Abstract available


    June 2018
  36. DE SEMIR D, Bezrookove V, Nosrati M, Dar AA, et al
    PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer.
    Proc Natl Acad Sci U S A. 2018 Jun 4. pii: 1804779115.
    PubMed     Abstract available


    April 2018
  37. ZHAO L, Huang S, Mei S, Yang Z, et al
    Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis.
    Proc Natl Acad Sci U S A. 2018;115:E3673-E3681.
    PubMed     Abstract available


    March 2018
  38. LI J, Wu C, Wang W, He Y, et al
    Structurally modulated codelivery of siRNA and Argonaute 2 for enhanced RNA interference.
    Proc Natl Acad Sci U S A. 2018;115:E2696-E2705.
    PubMed     Abstract available


    February 2018
  39. YATES K, Bi K, Haining WN, Cantor H, et al
    Comparative transcriptome analysis reveals distinct genetic modules associated with Helios expression in intratumoral regulatory T cells.
    Proc Natl Acad Sci U S A. 2018;115:2162-2167.
    PubMed     Abstract available


  40. HONG X, Sullivan RJ, Kalinich M, Kwan TT, et al
    Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy.
    Proc Natl Acad Sci U S A. 2018 Feb 16. pii: 1719264115.
    PubMed     Abstract available


    January 2018
  41. TAGGART D, Andreou T, Scott KJ, Williams J, et al
    Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8(+) T cell trafficking.
    Proc Natl Acad Sci U S A. 2018 Jan 31. pii: 1714089115.
    PubMed     Abstract available


    December 2017
  42. SU Y, Wei W, Robert L, Xue M, et al
    Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1712064115.
    PubMed     Abstract available


    October 2017
  43. MGRDITCHIAN T, Arakelian T, Paggetti J, Noman MZ, et al
    Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner.
    Proc Natl Acad Sci U S A. 2017;114:E9271-E9279.
    PubMed     Abstract available


    September 2017
  44. INGRAM JR, Blomberg OS, Sockolosky JT, Ali L, et al
    Localized CD47 blockade enhances immunotherapy for murine melanoma.
    Proc Natl Acad Sci U S A. 2017 Sep 5. pii: 201710776.
    PubMed     Abstract available


    August 2017
  45. DUGGAN MC, Stiff AR, Bainazar M, Regan K, et al
    Identification of NRAS isoform 2 overexpression as a mechanism facilitating BRAF inhibitor resistance in malignant melanoma.
    Proc Natl Acad Sci U S A. 2017 Aug 21. pii: 201704371.
    PubMed     Abstract available


    July 2017
  46. DU W, Seah I, Bougazzoul O, Choi G, et al
    Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas.
    Proc Natl Acad Sci U S A. 2017 Jul 14. pii: 201700363.
    PubMed     Abstract available


  47. LUNAVAT TR, Cheng L, Einarsdottir BO, Olofsson Bagge R, et al
    BRAFV600 inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells.
    Proc Natl Acad Sci U S A. 2017 Jul 6. pii: 201705206.
    PubMed     Abstract available


    June 2017
  48. TURRIANI E, Lazaro DF, Ryazanov S, Leonov A, et al
    Treatment with diphenyl-pyrazole compound anle138b/c reveals that alpha-synuclein protects melanoma cells from autophagic cell death.
    Proc Natl Acad Sci U S A. 2017 Jun 5. pii: 201700200.
    PubMed     Abstract available


    December 2016
  49. KEGELMAN TP, Wu B, Das SK, Talukdar S, et al
    Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
    Proc Natl Acad Sci U S A. 2016 Dec 23. pii: 201616100.
    PubMed     Abstract available


    November 2016
  50. LI Y, Cheng HS, Chng WJ, Tergaonkar V, et al
    Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas.
    Proc Natl Acad Sci U S A. 2016 Nov 23. pii: 201611106.
    PubMed     Abstract available


  51. DANILOVA L, Wang H, Sunshine J, Kaunitz GJ, et al
    Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors.
    Proc Natl Acad Sci U S A. 2016 Nov 11. pii: 201607836.
    PubMed     Abstract available


  52. SPRANGER S, Luke JJ, Bao R, Zha Y, et al
    Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.
    Proc Natl Acad Sci U S A. 2016 Nov 11. pii: 201609376.
    PubMed     Abstract available


    May 2016
  53. NAKAGAWA H, Sido JM, Reyes EE, Kiers V, et al
    Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity.
    Proc Natl Acad Sci U S A. 2016;113:6248-53.
    PubMed     Abstract available


    April 2016
  54. ADAR S, Hu J, Lieb JD, Sancar A, et al
    Genome-wide kinetics of DNA excision repair in relation to chromatin state and mutagenesis.
    Proc Natl Acad Sci U S A. 2016;113:E2124-33.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: